ACCCBUZZ BLOG

Fueled by advances in digital health technology and the growing need to address operational constraints in nonacademic settings, decentralized clinical trial designs are poised to redefine how (and where) clinical evidence is generated.

Instead of viewing clinical trials as a last resort, patients with pancreatic cancer and their oncologists are encouraged to investigate clinical trials from the start of treatment.

In honor of Juneteenth, ACCC President Dr. Nadine J. Barrett and AACI President Dr. Robert A. Winn engaged in an empowering conversation about a shared organizational goal to advance equitable cancer care.

The panel at the FDA OCE 4th Annual National Black Family Cancer Awareness Week, Engaging the Generations Conversation on Cancer, forum, explores family and faith in cancer care.

The FDA OCE recognizes National Black Family Cancer Awareness Month in this compelling panel discussion that explores cancer care disparities and much more.

Learn how patient-reported outcomes can improve comprehensive cancer care and promote health equity across community cancer centers.

ACCCBuzz recognizes June as Cancer Immunotherapy Month.

ACCC recognizes National Cancer Research Month.

LUNGevity invited ACCC and other stakeholders across the oncology world to Washington DC, for their second Health Equity Summit on Tuesday, March 12.

ACCC recognizes April as National Cancer Prevention and Early Detection Month.

Explore findings from a multi-stakeholder collaboration aimed at exploring clinical meaningfulness in comprehensive care delivery for patients with metastatic breast cancer.

Explore key takeaways from a meeting between ACCC, Inova Schar Cancer Institute, and delegates from the Swedish Ministry of Health and Social Affairs.

Highlights from the final day of the ACCC 50th Annual Meeting & Cancer Center Business Summit (#AMCCBS).

Evaluate recommendations on improving clinical trial diversity among patients with acute myeloid leukemia.

This is the second post of a three-part series on Modern Healthcare’s Social Determinants of Health Symposium.

ACCC, ACS CAN, and LUNGevity, launched a series of focus groups earlier this year aimed at making the case for increasing access to comprehensive genomic profiling for Medicaid beneficiaries.

At the ACCC 40th NOC, an exclusive EHR Working Summit was held to understand and explore effective practices/workaround solutions for streamlined biomarker test ordering and results management.

Equitable access to precision medicine should be a right to which all patients with cancer are entitled regardless of their insurance coverage or type. Read more about ACCC’s efforts to help Medicaid beneficiaries overcome financial barriers to biomarker testing.

ACCC president Olalekan Ajayi, PharmD, MBA, shared the association’s key priorities for impacting cancer care in the United States with the President’s Cancer Panel.

Let’s Win Pancreatic Cancer provides a road map of resources to help newly diagnosed patients with pancreatic cancer obtain the resources they need throughout their care journey.

Through a series of education projects, ACCC is committed to providing the resources the multidisciplinary cancer care team will need to navigate the complex precision medicine landscape and deliver next generation cancer care.

In the era of personalized medicine, biomarker testing is a tool the oncology workforce can and should leverage to deliver next generation cancer care.